FDA Grants Boston Scientific Clearance To Expand PolarCath(TM) Peripheral Dilatation System Offering With New Balloon Length
Tue, 30 Jan 2007 08:00 AM EST
... Boston Scientific Corporation (NYSE: BSX) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to expand its PolarCath(TM) Peripheral Dilatation System offering to include a 100-millimeter (mm) balloon. [click link for full article] ...
Related Topics
- Creatinine Clearance
- Peripheral Neuropathy
- Angioplasty
- Immune System
- Peripheral Vascular Disease
- Digestive System
- Endocrine System
- Health System
- Creatinine
- Vascular Disease
- Neuropathy
- Mammography
- Peripheral Blood Stem Cells
- Peripheral Nerve Disorders
- Lymphatic Diseases
- Tacrolimus ointment
- Tularemia
- Oral Health
- Western/Clinical Treatment and Therapy
- Neurological Diseases And Disorders

Not Signed In -


